Literature DB >> 2685529

Acute vincristine neurotoxicity in the presence of hereditary motor and sensory neuropathy type I.

S A McGuire1, S M Gospe, G Dahl.   

Abstract

Acute vincristine neurotoxicity leading to a severe motor and sensory neuropathy has been noted in patients with hereditary motor and sensory neuropathy type I (HMSN-I). The case of a 2-year-old boy with acute lymphocytic leukemia and HMSN-I is reported, and additional cases from the literature are reviewed. Severe vincristine neurotoxicity in patients with HMSN-I may be secondary to impairment of both slow and- fast axonal transport. Vincristine should be used with caution in patients with a family history of polyneuropathy.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2685529     DOI: 10.1002/mpo.2950170534

Source DB:  PubMed          Journal:  Med Pediatr Oncol        ISSN: 0098-1532


  4 in total

Review 1.  Vincristine-induced peripheral neuropathy in pediatric cancer patients.

Authors:  Erika Mora; Ellen M Lavoie Smith; Clare Donohoe; Daniel L Hertz
Journal:  Am J Cancer Res       Date:  2016-11-01       Impact factor: 6.166

2.  Vincristine treatment revealing asymptomatic hereditary motor sensory neuropathy type 1A.

Authors:  E Mercuri; J Poulton; J Buck; V Broadbent; M Bamford; H Jungbluth; A Y Manzur; F Muntoni
Journal:  Arch Dis Child       Date:  1999-11       Impact factor: 3.791

3.  Effective treatment of advanced Hodgkin lymphoma with a modified BEACOPP regimen for a patient with demyelinating hereditary motor and sensory neuropathy type 1 (HMSN1).

Authors:  Patrick P Hess; Monica S Ventura Ferreira; Benjamin Rolles; Martin Kirschner; Florian Holtbernd; Mareike Tometten; Tim H Brümmendorf; Fabian Beier
Journal:  Clin Case Rep       Date:  2022-05-05

Review 4.  Vinca alkaloids.

Authors:  Maryam Moudi; Rusea Go; Christina Yong Seok Yien; Mohd Nazre
Journal:  Int J Prev Med       Date:  2013-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.